4.945

1.88% -0.115

Myriad Genetics Inc (MYGN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché MYGN Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$5.06

Aprire:

$4.91

Volume 24 ore:

1.01M

Relative Volume:

0.84

Capitalizzazione di mercato:

$463.80M

Reddito:

$824.50M

Utile/perdita netta:

$-365.90M

Rapporto P/E:

-1.2509

EPS:

-3.9531

Flusso di cassa netto:

$-25.60M

1 W Prestazione:

-3.22%

1M Prestazione:

+9.60%

6M Prestazione:

-31.42%

1 anno Prestazione:

-52.31%

Intervallo 1D:

$4.75

$5.105

Intervallo di 1 settimana:

$4.75

$5.47

Portata 52W:

$3.76

$10.47

Myriad Genetics Inc Stock (MYGN) Company Profile

Nome

Myriad Genetics Inc

Settore

Healthcare (1115)

Industria

Diagnostics & Research (53)

Telefono

801-584-3600

Indirizzo

322 NORTH 2200 WEST, SALT LAKE CITY, UT

Dipendente

2,700

Cinguettio

@myriadgenetics

Prossima data di guadagno

2025-02-24

Ultimi documenti SEC

MYGN's Discussions on Twitter

Compare MYGN vs TMO, DHR, IDXX, A, WAT

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MYGN Myriad Genetics Inc	4.96	473.15M	824.50M	-365.90M	-25.60M	-3.9531
TMO Thermo Fisher Scientific Inc	476.77	184.15B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	188.30	137.93B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	578.50	47.82B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	111.79	32.62B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	287.74	29.19B	3.17B	642.63M	516.49M	10.77

Myriad Genetics Inc Stock (MYGN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-05-21	Downgrade	Scotiabank	Sector Outperform → Sector Perform
2025-05-08	Downgrade	Wolfe Research	Outperform → Peer Perform
2025-05-07	Downgrade	Wells Fargo	Overweight → Equal Weight
2025-04-09	Downgrade	Guggenheim	Buy → Neutral
2025-03-12	Aggiornamento	Piper Sandler	Neutral → Overweight
2025-02-12	Iniziato	Craig Hallum	Buy
2024-12-10	Iniziato	UBS	Neutral
2024-12-09	Downgrade	Leerink Partners	Outperform → Market Perform
2024-09-19	Iniziato	Morgan Stanley	Equal-Weight
2024-08-28	Iniziato	Wells Fargo	Overweight
2024-06-27	Iniziato	Scotiabank	Sector Outperform
2024-06-03	Ripresa	Jefferies	Underperform
2024-05-08	Aggiornamento	Leerink Partners	Market Perform → Outperform
2023-12-21	Ripresa	Piper Sandler	Neutral
2023-12-19	Iniziato	Wells Fargo	Equal Weight
2023-12-14	Iniziato	Guggenheim	Buy
2023-12-13	Iniziato	Wolfe Research	Outperform
2023-07-05	Ripresa	JP Morgan	Underweight
2023-05-23	Aggiornamento	Goldman	Sell → Buy
2023-01-18	Aggiornamento	Raymond James	Mkt Perform → Outperform
2022-10-06	Iniziato	Stephens	Equal-Weight
2021-10-15	Ripresa	Cowen	Market Perform
2021-06-15	Iniziato	Raymond James	Mkt Perform
2021-06-03	Iniziato	Goldman	Sell
2019-09-26	Downgrade	BofA/Merrill	Neutral → Underperform
2019-08-14	Downgrade	Piper Jaffray	Overweight → Neutral
2019-08-02	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-08-01	Aggiornamento	Barclays	Underweight → Equal Weight
2019-07-29	Downgrade	Needham	Strong Buy → Hold
2019-07-09	Downgrade	Cowen	Outperform → Market Perform
2019-03-12	Reiterato	Needham	Strong Buy
2019-01-03	Iniziato	Needham	Strong Buy
2018-11-30	Aggiornamento	Goldman	Sell → Neutral
2018-10-10	Aggiornamento	Piper Jaffray	Neutral → Overweight
2018-07-11	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2018-03-21	Aggiornamento	Morgan Stanley	Underweight → Equal-Weight
2018-01-29	Iniziato	Goldman	Sell
2018-01-22	Reiterato	Barclays	Equal Weight
2018-01-05	Iniziato	BTIG Research	Buy
2017-10-02	Ripresa	Leerink Partners	Mkt Perform
2017-08-09	Reiterato	Barclays	Equal Weight
2017-02-08	Aggiornamento	Ladenburg Thalmann	Sell → Neutral
2017-01-18	Iniziato	Deutsche Bank	Sell
2016-10-10	Downgrade	Ladenburg Thalmann	Neutral → Sell

Mostra tutto

Myriad Genetics Inc Borsa (MYGN) Ultime notizie

Mar 11, 2026

3 Reasons to Sell MYGN and 1 Stock to Buy Instead - Yahoo Finance

Mar 11, 2026

Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc - Yahoo Finance

Mar 11, 2026

Mar 10, 2026

Myriad Genetics at Leerink Conference: Strategic Moves in Cancer Care By Investing.com - Investing.com Canada

Mar 10, 2026

Trading Recap: Whats next for Myriad Genetics Inc stockBreakout Watch & Consistent Return Strategy Ideas - baoquankhu1.vn

Mar 06, 2026

Take Profit: What hedge funds are buying Myriad Genetics IncMarket Sentiment Review & Weekly High Momentum Picks - baoquankhu1.vn

Mar 06, 2026

Mar 05, 2026

Royce & Associates LP Makes New $4.84 Million Investment in Myriad Genetics, Inc. $MYGN - MarketBeat

Mar 05, 2026

Mar 04, 2026

Myriad Genetics Stock Up on New Breast Cancer MRD Test Launch | 2026News and Statistics - IndexBox

Mar 04, 2026

MYGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026

Mar 03, 2026

Myriad Genetics (MYGN) Stock Trades Up, Here Is Why - Finviz

Mar 03, 2026

Mar 02, 2026

Myriad Commercially Launches Precise MRD with Select Community Oncologists - Bitget

Mar 02, 2026

Myriad Genetics (MYGN) CPO has shares withheld to cover taxes - Stock Titan

Mar 02, 2026

Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Mar 02, 2026

Feb 28, 2026

Myriad Genetics (NASDAQ:MYGN) Stock Rating Upgraded by Zacks Research - MarketBeat

Feb 28, 2026

MYGN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 28, 2026

Feb 27, 2026

PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know - Yahoo Finance

Feb 27, 2026

Myriad Genetics (NASDAQ:MYGN) Director S. Louise Phanstiel Buys 48,000 Shares - MarketBeat

Feb 27, 2026

Insider Buying: Myriad Genetics (NASDAQ:MYGN) Director Acquires 6,100 Shares of Stock - MarketBeat

Feb 27, 2026

S. Louise Phanstiel Acquires 50,407 Shares of Myriad Genetics (NASDAQ:MYGN) Stock - MarketBeat

Feb 27, 2026

Myriad Genetics Insider Bought Shares Worth $494,722, According to a Recent SEC Filing - marketscreener.com

Feb 27, 2026

Director Phanstiel adds 104,507 Myriad Genetics (MYGN) shares - Stock Titan

Feb 27, 2026